AAS
CELZ icon

Ameritas Advisory Services’s Creative Medical Technology CELZ Stock Holding History

Ameritas Advisory Services’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,276
Closed -$6.03K – 2242
2025
Q2 		$6.03K Buy
+2,276
New +$4.9K ﹤0.01% 2182

Other funds holding CELZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameritas Advisory Services's CELZ Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Creative Medical Technology (CELZ) in Q3 2025, closing a stake of 2,276 shares — an estimated $6.03K sold.

Ameritas Advisory Services first reported a position in CELZ in Q2 2025 and held it in 1 quarter. The position peaked at $6.03K in Q2 2025. 12 funds tracked by Wall St. Rank hold CELZ as of Q3 2025.

  • Ameritas Advisory Services reported no remaining Creative Medical Technology position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 2,276 Creative Medical Technology shares in Q3 2025, an estimated $6.03K.
  • Ameritas Advisory Services first reported a position in Creative Medical Technology in Q2 2025 and held it in 1 quarter.
  • Ameritas Advisory Services's Creative Medical Technology position peaked at $6.03K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held Creative Medical Technology as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.